Double Down on Treatment
A combination therapy
Meet TALZENNA
TALZENNA is a prescription medicine used in combination with a medicine called enzalutamide, to treat adults with prostate cancer
- with certain abnormal inherited or acquired genes called homologous recombination repair (HRR genes) and
- which no longer responds to hormone therapy or surgical treatment to lower testosterone and has spread to other parts of the body (metastatic).
This is also called homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer (mCRPC).
Once-Daily Oral Treatment
TALZENNA is a pill—not chemotherapy or an injection. It’s taken:
Once a day
With or without food
Learn more about how to take TALZENNA.
Tips That May Help With Certain Side Effects
Learn about common side effects and discover tips that could be helpful.
Explore the Patient Brochure
Save it to your device or print it out for easy reference about TALZENNA.
MyTherapy® App
Check out this free app for customized TALZENNA content to support you along your treatment journey. It’s available on the App Store and Google Play, and includes:
- Medication reminders
- Support services and tools
- Progress tracker with a shareable health report
App Store is a service mark of Apple Inc., registered in the U.S. and other countries. Google Play and the Google Play logo are trademarks of Google LLC.
